Evolus Inc

-0.22 (-2.43%)
Stock Name Stock Symbol Market Stock Type
Evolus Inc EOLS NASDAQ Common Stock
  Price Change Price Change % Stock Price Last Trade
-0.22 -2.43% 8.83 09:16:09
Open Price Low Price High Price Close Price Previous Close
9.00 8.66 9.07 8.67 9.05
more quote information »

Recent News

Date Time Source Heading
10/5/202308:21EDGARStatement of Changes in Beneficial Ownership (4)
10/5/202307:13EDGARQuarterly Report (10-q)
10/5/202306:24EDGARAmended Statement of Ownership (sc 13g/a)
10/5/202306:08EDGARCurrent Report Filing (8-k)
10/5/202306:01BWEvolus Announces Expansion into U.S. Dermal Filler Market..
09/5/202306:04EDGARProxy Statement (definitive) (def 14a)
09/5/202306:02EDGARAnnual Report to Security Holders (ars)
06/5/202303:37BWEvolus to Report First Quarter 2023 Results and Provide..
27/4/202307:09EDGARProxy Statement - Notice of Shareholders Meeting..
15/4/202307:13EDGARSecurities Registration Statement (simplified Form) (s-3/a)
30/3/202308:12EDGARStatement of Changes in Beneficial Ownership (4)
17/3/202310:03EDGARStatement of Changes in Beneficial Ownership (4)
17/3/202310:03EDGARStatement of Changes in Beneficial Ownership (4)
14/3/202300:01EDGARCurrent Report Filing (8-k)
09/3/202309:14EDGARSecurities Registration Statement (simplified Form) (s-3)
09/3/202308:43EDGARSecurities Registration: Employee Benefit Plan (s-8)
09/3/202308:38EDGARAnnual Report (10-k)
09/3/202308:05BWEvolus Reports Fourth Quarter and Full Year 2022 Results and..
01/3/202300:45BWEvolus to Participate in the Barclays Global Healthcare..
28/2/202300:45BWEvolus Initiates Nuceiva® Launch in Germany and Austria
23/2/202308:02EDGARStatement of Changes in Beneficial Ownership (4)
23/2/202300:45BWEvolus to Report Fourth Quarter and Year End 2022 Results..
22/2/202308:01EDGARStatement of Ownership (sc 13g)
15/2/202306:34EDGARAmended Statement of Ownership (sc 13g/a)
11/2/202303:07BWEvolus Not Affected by Recent Korean Court Ruling
11/2/202301:32EDGARAmended Statement of Ownership (sc 13g/a)
07/2/202308:13EDGARAmended Statement of Ownership (sc 13g/a)
01/2/202300:45BWEvolus to Participate in the SVB Securities Global Biopharma..
29/1/202300:00BW"Extra-Strength" Formulation of Jeuveau® Demonstrates..
24/1/202301:00BWEvolus Receives Regulatory Approval for Nuceiva® in..
24/1/202300:00BWEvolus to Present Phase 2 Interim Data from Jeuveau®..
19/1/202300:45BWEvolus Announces Preliminary Unaudited Fourth Quarter and..
09/12/202201:22EDGARCurrent Report Filing (8-k)
09/12/202200:45BWEvolus Extends Term of Credit Facility with Pharmakon..
08/12/202202:00PRNUSLeading MedTech marketplace Pipeline Medical now provides..
10/11/202215:26TRMNSVB Securities Sticks to Its Buy Rating for Evolus (EOLS)
09/11/202223:15TRMNNeedham Keeps Their Buy Rating on Evolus (EOLS)
09/11/202222:25TRMNH.C. Wainwright Reaffirms Their Buy Rating on Evolus (EOLS)
09/11/202209:04EDGARQuarterly Report (10-q)
09/11/202208:05BWEvolus Reports Third Quarter 2022 Results and Provides..
02/11/202223:45BWEvolus to Participate in November Conferences
25/10/202223:45BWEvolus to Report Third Quarter 2022 Results and Provide..
08/10/202207:13EDGARStatement of Changes in Beneficial Ownership (4)
07/10/202207:19EDGARStatement of Changes in Beneficial Ownership (4)
04/10/202223:20BWEvolus Broadens Its International Presence with Nuceiva®..
21/9/202222:45BWEvolus Concludes Certain Royalty Payments; Financial Profile..
17/9/202206:11EDGARStatement of Changes in Beneficial Ownership (4)
14/9/202207:58EDGARAmended Statement of Changes in Beneficial Ownership (4/a)
14/9/202207:58EDGARStatement of Changes in Beneficial Ownership (4)
13/9/202207:46EDGARStatement of Changes in Beneficial Ownership (4)
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 | help@advfn.com

V: D: 20230602 02:06:10